Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Prospective, Active Controlled, Study of the Epi-Rad90™ Ophthalmic System for the Treatment of Subfoveal Choroidal Neovascularization Associated With Wet Age-Related Macular Degeneration

NCT00454389 is registered in ClinicalTrials.gov with NeoVista as lead sponsor.

NCT NCT00454389
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00454389 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Prospective, Active Controlled, Study of the Epi-Rad90™ Ophthalmic System for the Treatment of Subfoveal Choroidal Neovascularization Associated With Wet Age-Related Macular Degeneration
Lead sponsor
NeoVista
Phase
Phase 3
Overall status
Unknown status
Start date
April 30, 2007
Completion date
August 31, 2012
Enrollment
494 (actual)
Sites
32

Conditions

As the registry lists them; a condition with its own page is linked.

macular degeneration